News

The drug will follow a four-week cycle for dosage, starting with the smallest dose of 0.25 mg per week for four weeks, ...
Danish company Novo Nordisk is set to launch Wegovy for weight loss, in India on Tuesday. The injectable product, called the ...
An article published in the journal Nature Metabolism presents an experimental drug that stimulates adipose tissue cells to ...
Danish pharmaceutical company Novo Nordisk on Tuesday announced the launch of its weight-loss drug Wegovy, an injectable ...
Novo Nordisk has officially launched its anti-obesity drug Wegovy in India ahead of patent expiry. This move aims to tackle rising obesity rates while facing competition from rival drugs.
Arthritis awareness emphasizes early detection of arthritis, a condition affecting joints, bones, and muscles. Recognizing ...